Fulvestrant Faslodex (CAS: 129453-61-8)

Product Description

Anti-Estrogen Steroids Faslodex Hormonal Faslodex 129453-61-8 For Cancer Treatment

1. Quick Detail: Alias: Faslodex AstraZeneca CAS Registry Number: 129453-61-8 Assay: 97.0%~103.0% Molecular Fomular: C32H47F5O3S Molecular Weight: 606.77 Density: 1.201 g/cm3 Melting Point: 104-106º C Appearance: White powder Grade: Pharmaceutical Grade Storage: Shading, confined preservation Manufacturer: GONGCHUANG Delivery: EMS, DHL, TNT, FedEx, UPS

2. Applications:

In particular 4 clinical trials in this setting did show similar efficacy to the other hormonal agents (aromatase inhibitors and tamoxifen) with good tolerability profile. Fulvestrant had a lower incidence of joint disorders.

Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells.

Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.

Sodium L-Triiodothyronine(T3) CAS NO:55-06-1 Chemical name:3,3',5-Triiodo-L-thyronine, sodium salt Molecular formula:C15H12I3NO4 Molecular Weight:650.97 Molecular Structure: Content:(%):99 Boiling point:205°C water-solubility:4 M NH4OH in methanol: 125 g/5mL, clear, yellow-brown